Oral antibiotic use and chronic disease: long-term health impact beyond antimicrobial resistance and Clostridioides difficile

References

• Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, Laxminarayan R. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–750. doi:10.1016/S1473-3099(14)70780-7.
   Google Scholar
• Klein EY, Van Boeckel TP, Martinez EM, Pant S, Gandra S, Levin SA, Goossens H, Laxminarayan R. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115(15):E3463–E3470. doi:10.1073/pnas.1717295115.
   Google Scholar
• Prevention CfDCa. Outpatient antibiotic prescriptions — United States. Outpatient Antibiotic Prescriptions — United States; 2016.
   Google Scholar
• Lee GC, Reveles KR, Attridge RT, Lawson KA, Mansi IA, Lewis JS, Frei CR. Outpatient antibiotic prescribing in the united states: 2000 to 2010. BMC Med. 2014;12(96). doi:10.1186/1741-7015-12-96.
   Google Scholar
• Dolk FCK, Pouwels KB, Smith DRM, Robotham JV, Smieszek T. Antibiotics in primary care in england: which antibiotics are prescribed and for which conditions? J Antimicrob Chemother. 2018;73(suppl_2):ii2–ii10. doi:10.1093/jac/dkx504.
   Google Scholar
• Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM, Finkelstein JA, Gerber JS, Hyun DY, Linder JA, et al. Prevalence of inappropriate antibiotic prescriptions among us ambulatory care visits, 2010-2011. JAMA. 2016;315(17):1864–1873. doi:10.1001/jama.2016.4151.
   Google Scholar
• Smieszek T, Pouwels KB, Dolk FCK, Smith DRM, Hopkins S, Sharland M, Hay AD, Moore MV, Robotham JV. Potential for reducing inappropriate antibiotic prescribing in english primary care. J Antimicrob Chemother. 2018;73(suppl_2):ii36–ii43. doi:10.1093/jac/dkx500.
   Google Scholar
• Drewes JL, White JR, Dejea CM, Fathi P, Iyadorai T, Vadivelu J, Roslani AC, Wick EC, Mongodin EF, Loke MF, et al. High-resolution bacterial 16s rrna gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia. NPJ Biofilms Microbiomes. 2017;3(34). doi:10.1038/s41522-017-0040-3.
   Google Scholar
• Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, Wu X, DeStefano Shields CE, Hechenbleikner EM, Huso DL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359(6375):592–597. doi:10.1126/science.aah3648.
   Google Scholar
• Dejea CM, Wick EC, Hechenbleikner EM, White JR, Mark Welch JL, Rossetti BJ, Peterson SN, Snesrud EC, Borisy GG, Lazarev M, et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A. 2014;111(51):18321–18326. doi:10.1073/pnas.1406199111.
   Google Scholar
• Tomkovich S, Dejea CM, Winglee K, Drewes JL, Chung L, Housseau F, Pope JL, Gauthier J, Sun X, Mühlbauer M, et al. Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic. J Clin Invest. 2019;130:1699–1712. doi:10.1172/JCI124196.
   Google Scholar
• Zhang H, García Rodríguez LA, Hernández-Díaz S. Antibiotic use and the risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(6):1308–1315. doi:10.1158/1055-9965.EPI-07-2817.
   Google Scholar
• Kilkkinen A, Rissanen H, Klaukka T, Pukkala E, Heliövaara M, Huovinen P, Männistö S, Aromaa A, Knekt P. Antibiotic use predicts an increased risk of cancer. Int J Cancer. 2008;123(9):2152–2155. doi:10.1002/ijc.v123:9.
   Google Scholar
• Yang B, Hagberg KW, Chen J, Sahasrabuddhe VV, Graubard BI, Jick S, McGlynn KA. Associations of antibiotic use with risk of primary liver cancer in the clinical practice research datalink. Br J Cancer. 2016;115(1):85–89. doi:10.1038/bjc.2016.148.
   Google Scholar
• Boursi B, Mamtani R, Haynes K, Yang YX. Recurrent antibiotic exposure may promote cancer formation–another step in understanding the role of the human microbiota?. Eur J Cancer. 2015;51(17):2655–2664. doi:10.1016/j.ejca.2015.08.015.
   Google Scholar
• Cao Y, Wu K, Mehta R, Drew DA, Song M, Lochhead P, Nguyen LH, Izard J, Fuchs CS, Garrett WS, et al. Long-term use of antibiotics and risk of colorectal adenoma. Gut. 2018;67(4):672–678. doi:10.1136/gutjnl-2016-313413.
   Google Scholar
• Tamim HM, Hajeer AH, Boivin JF, Collet JP. Association between antibiotic use and risk of prostate cancer. Int J Cancer. 2010;127(4):952–960. doi:10.1002/ijc.25139.
   Google Scholar
• Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA. 2004;291(7):827–835. doi:10.1001/jama.291.7.827.
   Google Scholar
• Hoskin-Parr L, Teyhan A, Blocker A, Henderson AJ. Antibiotic exposure in the first two years of life and development of asthma and other allergic diseases by 7.5 yr: A dose-dependent relationship. Pediatr Allergy Immunol. 2013;24(8):762–771. doi:10.1111/pai.12153.
   Google Scholar
• Risnes KR, Belanger K, Murk W, Bracken MB. Antibiotic exposure by 6 months and asthma and allergy at 6 years: findings in a cohort of 1,401 us children. Am J Epidemiol. 2011;173(3):310–318. doi:10.1093/aje/kwq400.
   Google Scholar
• Arvonen M, Virta LJ, Pokka T, Kröger L, Vähäsalo P. Repeated exposure to antibiotics in infancy: A predisposing factor for juvenile idiopathic arthritis or a sign of this group’s greater susceptibility to infections? J Rheumatol. 2015;42(3):521–526. doi:10.3899/jrheum.140348.
   Google Scholar
• Card T, Logan RF, Rodrigues LC, Wheeler JG. Antibiotic use and the development of crohn’s disease. Gut. 2004;53(2):246–250. doi:10.1136/gut.2003.025239.
   Google Scholar
• Hviid A, Svanström H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011;60(1):49–54. doi:10.1136/gut.2010.219683.
   Google Scholar
• Kronman MP, Zaoutis TE, Haynes K, Feng R, Coffin SE. Antibiotic exposure and ibd development among children: A population-based cohort study. Pediatrics. 2012;130(4):e794–803. doi:10.1542/peds.2011-3886.
   Google Scholar
• Boursi B, Mamtani R, Haynes K, Yang YX. The effect of past antibiotic exposure on diabetes risk. Eur J Endocrinol. 2015;172(6):639–648. doi:10.1530/EJE-14-1163.
   Google Scholar
• Mueller NT, Whyatt R, Hoepner L, Oberfield S, Dominguez-Bello MG, Widen EM, Hassoun A, Perera F, Rundle A. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes (Lond). 2015;39(4):665–670. doi:10.1038/ijo.2014.180.
   Google Scholar
• Scott FI, Horton DB, Mamtani R, Haynes K, Goldberg DS, Lee DY, Lewis JD. Administration of antibiotics to children before age 2 years increases risk for childhood obesity. Gastroenterology. 2016;151(1):120–129.e125. doi:10.1053/j.gastro.2016.03.006.
   Google Scholar
• Schwartz BS, Pollak J, Bailey-Davis L, Hirsch AG, Cosgrove SE, Nau C, Kress AM, Glass TA, Bandeen-Roche K. Antibiotic use and childhood body mass index trajectory. Int J Obes (Lond). 2016;40(4):615–621. doi:10.1038/ijo.2015.218.
   Google Scholar
• Tasian GE, Jemielita T, Goldfarb DS, Copelovitch L, Gerber JS, Wu Q, Denburg MR. Oral antibiotic exposure and kidney stone disease. J Am Soc Nephrol. 2018;29(6):1731–1740. doi:10.1681/ASN.2017111213.
   Google Scholar
• Lurie I, Yang YX, Haynes K, Mamtani R, Boursi B. Antibiotic exposure and the risk for depression, anxiety, or psychosis: A nested case-control study. J Clin Psychiatry. 2015;76(11):1522–1528. doi:10.4088/JCP.15m09961.
   Google Scholar
• Yassour M, Vatanen T, Siljander H, Hämäläinen AM, Härkönen T, Ryhänen SJ, Franzosa EA, Vlamakis H, Huttenhower C, Gevers D, et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med. 2016;8(343):343ra381. doi:10.1126/scitranslmed.aad0917.
   Google Scholar
• Lichtman JS, Ferreyra JA, Ng KM, Smits SA, Sonnenburg JL, Elias JE. Host-microbiota interactions in the pathogenesis of antibiotic-associated diseases. Cell Rep. 2016;14(5):1049–1061. doi:10.1016/j.celrep.2016.01.009.
   Google Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16s rrna sequencing. PLoS Biol. 2008;6:e280.
   Google Scholar
• Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4554–4561. doi:10.1073/pnas.1000087107.
   Google Scholar
• Pérez-Cobas AE, Artacho A, Knecht H, Ferrús ML, Friedrichs A, Ott SJ, Moya A, Latorre A, Gosalbes MJ. Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS One. 2013;8(11):e80201. doi:10.1371/journal.pone.0080201.
   Google Scholar
• Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, Otto W, Rojo D, Bargiela R, von Bergen M, et al. Gut microbiota disturbance during antibiotic therapy: A multi-omic approach. Gut. 2013;62(11):1591–1601. doi:10.1136/gutjnl-2012-303184.
   Google Scholar
• Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. Isme J. 2007;1(1):56–66. doi:10.1038/ismej.2007.3.
   Google Scholar
• Vidal AC, Murphy SK, Murtha AP, Schildkraut JM, Soubry A, Huang Z, Neelon SE, Fuemmeler B, Iversen E, Wang F, et al. Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes (Lond). 2013;37(7):907–913. doi:10.1038/ijo.2013.47.
   Google Scholar
• Yu DH, Gadkari M, Zhou Q, Yu S, Gao N, Guan Y, Schady D, Roshan TN, Chen MH, Laritsky E, et al. Postnatal epigenetic regulation of intestinal stem cells requires dna methylation and is guided by the microbiome. Genome Biol. 2015;16:211. doi:10.1186/s13059-015-0763-5.
   Google Scholar
• Schumann A, Nutten S, Donnicola D, Comelli EM, Mansourian R, Cherbut C, Corthesy-Theulaz I, Garcia-Rodenas C. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics. 2005;23(2):235–245. doi:10.1152/physiolgenomics.00057.2005.
   Google Scholar
• Knoop KA, McDonald KG, Kulkarni DH, Newberry RD. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut. 2016;65(7):1100–1109. doi:10.1136/gutjnl-2014-309059.
   Google Scholar
• Knoop KA, Gustafsson JK, McDonald KG, Kulkarni DH, Kassel R, Newberry RD. Antibiotics promote the sampling of luminal antigens and bacteria via colonic goblet cell associated antigen passages. Gut Microbes. 2017;8(4):400–411. doi:10.1080/19490976.2017.1299846.
   Google Scholar
• Pevsner-Fischer M, Tuganbaev T, Meijer M, Zhang SH, Zeng ZR, Chen MH, Elinav E. Role of the microbiome in non-gastrointestinal cancers. World J Clin Oncol. 2016;7(2):200–213. doi:10.5306/wjco.v7.i2.200.
   Google Scholar
• Tsilimigras MC, Fodor A, Jobin C. Carcinogenesis and therapeutics: the microbiota perspective. Nat Microbiol. 2017;2:17008. doi:10.1038/nmicrobiol.2017.8.
   Google Scholar
• Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2016;14(1):20–32. doi:10.1038/nrmicro3552.
   Google Scholar
• Chen J, Domingue JC, Sears CL. Microbiota dysbiosis in select human cancers: evidence of association and causality. Semin Immunol. 2017;32:25–34. doi:10.1016/j.smim.2017.08.001.
   Google Scholar
• Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA, Masugi Y, Shi Y, Song M, da Silva A, Gu M, et al. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin Transl Gastroenterol. 2016;7(11):e200. doi:10.1038/ctg.2016.53.
   Google Scholar
• Vaughn VM, Gandhi T, Conlon A, Chopra V, Malani AN, Flanders SA. The association of antibiotic stewardship with fluoroquinolone prescribing in michigan hospitals: A multi-hospital cohort study. Clin Infect Dis. 2019;69(8):1269–1277. doi:10.1093/cid/ciy1102.
   Google Scholar
• Dunbar LM, Wunderink RG, Habib MP, Smith LG, Tennenberg AM, Khashab MM, Wiesinger BA, Xiang JX, Zadeikis N, Kahn JB. High-dose, short-course levofloxacin for community-acquired pneumonia: A new treatment paradigm. Clin Infect Dis. 2003;37(6):752–760. doi:10.1086/cid.2003.37.issue-6.
   Google Scholar
• El Moussaoui R, de Borgie CA, van den Broek P, Hustinx WN, Bresser P, van den Berk GE, Poley JW, van den Berg B, Krouwels FH, Bonten MJ, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ. 2006;332(7554):1355. doi:10.1136/bmj.332.7554.1355.
   Google Scholar
• Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the american thoracic society and infectious diseases society of america. Am J Respir Crit Care Med. 2019;200(7):e45–e67.
   Google Scholar
• Royer S, DeMerle KM, Dickson RP, Prescott HC. Shorter versus longer courses of antibiotics for infection in hospitalized patients: A systematic review and meta-analysis. J Hosp Med. 2018;13(5):336–342. doi:10.12788/jhm.2905.
   Google Scholar
• Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, Neuberger A, Ghanem-Zoubi N, Santoro A, Eliakim-Raz N, et al. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: A noninferiority randomized controlled trial. Clin Infect Dis. 2019;69(7):1091–1098. doi:10.1093/cid/ciy1054.
   Google Scholar
• LaVergne S, Hamilton T, Biswas B, Kumaraswamy M, Schooley RT, Wooten D. Phage therapy for a multidrug-resistant. Open Forum Infect Dis. 2018;5(4):ofy064. doi:10.1093/ofid/ofy064.
   Google Scholar
• Chan BK, Turner PE, Kim S, Mojibian HR, Elefteriades JA, Narayan D. Phage treatment of an aortic graft infected with. Evol Med Public Health. 2018;2018(1):60–66. doi:10.1093/emph/eoy005.
   Google Scholar
• Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant acinetobacter baumannii infection. Antimicrob Agents Chemother. 2017;61(10). doi:10.1128/AAC.00954-17.
   Google Scholar
• Ahmad V, Khan MS, Jamal QMS, Alzohairy MA, Al Karaawi MA, Siddiqui MU. Antimicrobial potential of bacteriocins: in therapy, agriculture and food preservation. Int J Antimicrob Agents. 2017;49(1):1–11. doi:10.1016/j.ijantimicag.2016.08.016.
   Google Scholar
• Mahlapuu M, Håkansson J, Ringstad L, Björn C. Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol. 2016;6:194. doi:10.3389/fcimb.2016.00194.
   Google Scholar
• Eckert R, He J, Yarbrough DK, Qi F, Anderson MH, Shi W. Targeted killing of streptococcus mutans by a pheromone-guided “Smart” Antimicrobial peptide. Antimicrob Agents Chemother. 2006;50(11):3651–3657. doi:10.1128/AAC.00622-06.
   Google Scholar
• Sullivan R, Santarpia P, Lavender S, Gittins E, Liu Z, Anderson MH, He J, Shi W, Eckert R. Clinical efficacy of a specifically targeted antimicrobial peptide mouth rinse: targeted elimination of streptococcus mutans and prevention of demineralization. Caries Res. 2011;45(5):415–428. doi:10.1159/000330510.
   Google Scholar
• Wang JL, Chang CH, Lin JW, Wu LC, Chuang LM, Lai MS. Infection, antibiotic therapy and risk of colorectal cancer: A nationwide nested case-control study in patients with type 2 diabetes mellitus. Int J Cancer. 2014;135(4):956–967. doi:10.1002/ijc.28738.
   Google Scholar
• Dik VK, van Oijen MG, Smeets HM, Siersema PD. Frequent use of antibiotics is associated with colorectal cancer risk: results of a nested case-control study. Dig Dis Sci. 2016;61(1):255–264. doi:10.1007/s10620-015-3828-0.
   Google Scholar